METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Clinical trials for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Find and Treat' approach tested for tough breast cancers
Disease control Recruiting nowThis early-stage study is testing a two-part approach for advanced breast cancer that has returned or spread. First, a new radioactive tracer (68Ga-R11228) is used in a PET scan to find cancer spots in the body. If the scan shows the cancer takes up the tracer, patients may then …
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New scan aims to sharpen the picture of stubborn breast cancer
Diagnosis Recruiting nowThis early-stage study is testing a new radioactive imaging tracer called 68Ga-R10602 to see if it can better locate tumors in people with advanced, hormone-positive breast cancer. The study will enroll about 36 adults whose cancer has progressed despite prior treatments. The mai…
Matched conditions: METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC